Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Priv.-Doz. Dr. med. Sied Kebir

Anschrift
Hufelandstraße 55
45147 Essen
Telefon
0201/83133
Telefax
0201/6985
E-Mail
sied.kebir@uk-essen.de
Webseite
http://neurologie.uk-essen.de
Sprechzeiten
ab 17 Uhr

Funktionen

  • Funktionsoberarzt/-ärztin, Klinik für Neurologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Oster, Christoph; Matyar, Aylin; Schmidt, Teresa; Hummel, Thomas; Hattingen, Elke; Jokisch, Martha; Jokisch, Daniel; Grieger, Jana; Cappello, Giorgio; Kizina, Kathrin; Lazaridis, Lazaros; Ahmadipour, Yahya; Rauschenbach, Laurèl; Stuschke, Martin; Pöttgen, Christoph; Guberina, Nika; Tertel, Tobias; Giebel, Bernd; Dreizner, Gian Luca; Barbato, Francesco; Skoda, Eva-Maria; Scheffler, Björn; Müther, Michael; Herrmann, Ken; Kleinschnitz, Christoph; Sure, Ulrich; Deuschl, Cornelius; Glas, Martin; Kebir, Sied
    Decoding glioblastoma survival : unraveling the prognostic potential of olfactory function in a prospective observational study
    In: Neurological Research and Practice, Jg. 7, 2025, Nr. 1, 51
    DOI (Open Access)
  • Oster, Christoph; Reineck, Pia; Schmidt, Teresa; Grieger, Jana; Sharma, Sandeep; Feldheim, Jonas; Kizina, Kathrin; Cappello, Giorgio; Jekel, Leon; Pabst, Kim M; Ahmadipour, Yahya; Karadachi, Hanah; Rauschenbach, Laurèl; Lazaridis, Lazaros; Guberina, Nika; Pöttgen, Christoph; Blau, Tobias; Keyvani, Kathy; Scheffler, Björn; Herrmann, Ken; Kleinschnitz, Christoph; Sure, Ulrich; Stuschke, Martin; Glas, Martin; Kebir, Sied
    Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort : Time to treat more aggressively?
    In: Neuro-Oncology Advances, 2025, in press
    DOI (Open Access)
  • Lazaridis, Lazaros; Moenninghoff, Christoph; Bumes, Elisabeth; Spille, Dorothee Cäcilia; Müther, Michael; Schulz, Tim; Heider, Sina; Agkatsev, Sarina; Schmidt, Teresa; Blau, Tobias; Oster, Christoph; Stummer, Walter; Kessler, Almuth Friederike; Seidel, Clemens; Grauer, Oliver; Hau, Peter; Ahmadipour, Yahya; Sure, Ulrich; Keyvani, Kathy; Herrlinger, Ulrich; Kleinschnitz, Christoph; Stuschke, Martin; Guberina, Nika; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin
    Temporal Muscle Thickness as a Prognostic Marker in a Real-Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma : A Multicentric Imaging Analysis
    In: Cancer Medicine, Jg. 14, 2025, Nr. 8, e70689
    DOI (Open Access)
  • Rauschenbach, Laurèl; Gerach, Felix M.; Berliner, Christoph; Blau, Tobias; Kebir, Sied; Dobersalske, Celia; Deuschl, Cornelius; Sure, Ulrich; Herrmann, Ken; Dammann, Philipp
    [⁶⁸Ga]-DOTA-conjugated somatostatin receptor-targeting peptide PET for the differentiation between meningioma and glioblastoma : A case report and review of the literature
    In: Oncology Letters, Jg. 29, 2025, Nr. 4, 199
    DOI (Open Access)
  • Latzer, Pauline; Zelba, Henning; Battke, Florian; Reinhardt, Annekathrin; Shao, Borong; Bartsch, Oliver; Rabsteyn, Armin; Harter, Johannes; Schulze, Martin; Okech, Thomas; Golf, Alexander; Kyzirakos-Feger, Christina; Kayser, Simone; Pieper, Natalia; Feldhahn, Magdalena; Wünsche, Julian; Seitz, Christian; Hadaschik, Dirk; Garbe, Claus; Hauser, Till-Karsten; la Fougère, Christian; Biskup, Dirk; Brooke, Dawn; Parker, David; Martens, Uwe M.; Illerhaus, Gerald; Blumenthal, Deborah T.; Merrell, Ryan; Lorenzo, Luisa Sánchez; Hidvégi, Máté; de Robles, Paula; Kebir, Sied; Li, William W.; Li, Vincent W.; Williams, Matthew; Miller, Alexandra M.; Kesari, Santosh; Castro, Michael; Desjardins, Annick; Ashley, David M.; Friedman, Henry S.; Wen, Patrick Y.; Neil, Elisabeth C.; Iwamoto, Fabio M.; Sipos, Bence; Geletneky, Karsten; Zender, Lars; Glas, Martin; Reardon, David A.; Biskup, Saskia
    A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
    In: Nature Communications, Jg. 15, 2024, Nr. 1, 6870
    DOI (Open Access)
  • Ullrich, Vivien; Ertmer, Sarah; Baginska, Anna; Dorsch, Madeleine; Gull, Hanah H.; Cima, Igor; Berger, Pia; Dobersalske, Celia; Langer, Sarah; Meyer, Loona; Dujardin, Philip; Kebir, Sied; Glas, Martin; Blau, Tobias; Keyvani, Kathy; Rauschenbach, Laurèl; Sure, Ulrich; Roesch, Alexander; Grüner, Barbara M.; Scheffler, Björn
    KDM5B predicts temozolomide-resistant subclones in glioblastoma
    In: iScience, Jg. 27, 2024, Nr. 1, 108596
    DOI (Open Access)
  • Giordano, Frank A.; Layer, Julian P.; Leonardelli, Sonia; Friker, Lea L.; Turiello, Roberta; Corvino, Dillon; Zeyen, Thomas; Schaub, Christina; Müller, Wolf; Sperk, Elena; Schmeel, Leonard Christopher; Sahm, Katharina; Oster, Christoph; Kebir, Sied; Hambsch, Peter; Pietsch, Torsten; Bisdas, Sotirios; Platten, Michael; Glas, Martin; Seidel, Clemens; Herrlinger, Ulrich; Hölzel, Michael
    L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial
    In: Nature Communications, Jg. 15, 2024, Nr. 1, 4210
    DOI (Open Access)
  • Rauschenbach, Laurèl; Kolbe, Pia; Engel, Adrian; Ahmadipour, Yahya; Oppong, Marvin Darkwah; Santos, Alejandro N.; Kebir, Sied; Dobersalske, Celia; Scheffler, Björn; Deuschl, Cornelius; Dammann, Philipp; Wrede, Karsten; Sure, Ulrich; Jabbarli, Ramazan
    Predictors and surgical outcome of hemorrhagic metastatic brain malignancies
    In: Journal of Neuro-Oncology, Jg. 169, 2024, Nr. 1, S. 165 – 173
    DOI (Open Access)
  • Oster, Christoph; Kessler, Lukas; Blau, Tobias; Keyvani, Kathy; Pabst, Kim M.; Fendler, Wolfgang; Fragoso Costa, Pedro; Lazaridis, Lazaros; Schmidt, Teresa; Feldheim, Jonas; Pierscianek, Daniela; Schildhaus, Hans-Ulrich; Sure, Ulrich; Ahmadipour, Yahya; Kleinschnitz, Christoph; Guberina, Nika; Stuschke, Martin; Deuschl, Cornelius; Scheffler, Björn; Herrmann, Ken; Kebir, Sied; Glas, Martin
    The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, ⁶⁸Ga-FAPI-46 PET Data, and Survival Data
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 8, S. 1217 – 1223
    DOI
  • Kebir, Sied; Ullrich, Vivien; Berger, Pia; Dobersalske, Celia; Langer, Sarah; Rauschenbach, Laurèl; Trageser, Daniel; Till, Andreas; Lorbeer, Franziska K.; Wieland, Anja; Wilhelm-Buchstab, Timo; Ahmad, Ashar; Fröhlich, Holger; Cima, Igor; Prasad, Shruthi; Matschke, Johann; Jendrossek, Verena; Remke, Marc; Grüner, Barbara M.; Rösch, Alexander; Siveke, Jens T.; Herold-Mende, Christel; Blau, Tobias; Keyvani, Kathy; van Landeghem, Frank K H; Pietsch, Torsten; Felsberg, Jörg; Reifenberger, Guido; Weller, Michael; Sure, Ulrich; Brüstle, Oliver; Simon, Matthias; Glas, Martin; Scheffler, Björn
    A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
    In: Clinical Cancer Research, Jg. 29, 2023, Nr. 2, S. 488 – 500
    DOI (Open Access)
  • Oster, Christoph; Schmidt, Teresa; Agkatsev, Sarina; Lazaridis, Lazaros; Kleinschnitz, Christoph; Sure, Ulrich; Scheffler, Björn; Kebir, Sied; Glas, Martin
    Are we providing best available care to newly diagnosed glioblastoma patients? : Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022
    In: Neuro-Oncology Advances, Jg. 5, 2023, Nr. 1, vdad105
    DOI, Online Volltext (Open Access)
  • Milosevic, Aleksandar; Styczen, Hanna; Haubold, Johannes; Kessler, Lukas; Grüneisen, Johannes; Li, Yan; Weber, Manuel; Fendler, Wolfgang; Morawitz, Janna; Damman, Philipp; Wrede, Karsten; Kebir, Sied; Glas, Martin; Guberina, Maja; Blau, Tobias; Schaarschmidt, Benedikt; Deuschl, Cornelius
    Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI
    In: Nuclear Medicine Communications, Jg. 44, 2023, Nr. 12, S. 1106 – 1113
    DOI
  • Schmidt, Teresa; Agkatsev, Sarina; Feldheim, Jonas; Oster, Christoph; Blau, Tobias; Sure, Ulrich; Keyvani, Kathy; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin; Lazaridis, Lazaros
    Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma
    In: Neuro-Oncology Advances, Jg. 5, 2023, Nr. 1, vdad090
    DOI, Online Volltext (Open Access)
  • Lazaridis, Lazaros; Schmidt, Teresa; Oster, Christoph; Blau, Tobias; Pierscianek, Daniela; Siveke, Jens T.; Bauer, Sebastian; Schildhaus, Hans-Ulrich; Sure, Ulrich; Keyvani, Kathy; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin
    Precision neuro-oncology : A pilot analysis of personalized treatment in recurrent glioma
    In: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 7, S. 3513 – 3526
    DOI (Open Access)
  • Feldheim, Jonas; Schmidt, Teresa; Oster, Christoph; Feldheim, Julia; Stuschke, Martin; Stummer, Walter; Grauer, Oliver; Scheffler, Björn; Hagemann, Carsten; Sure, Ulrich; Kleinschnitz, Christoph; Lazaridis, Lazaros; Kebir, Sied; Glas, Martin
    Telemedicine in Neuro-Oncology : An Evaluation of Remote Consultations during the COVID-19 Pandemic
    In: Cancers, Jg. 15, 2023, Nr. 16, 4054
    DOI (Open Access)
  • Kebir, Sied; Lazaridis, Lazaros; Wick, Wolfgang; Platten, Michael; Tabatabai, Ghazaleh; Combs, Stephanie E.; Schmidt, Teresa; Agkatsev, Sarina; Blau, Tobias; Mäurer, Irina; Kahlert, Ulf; Sagerer, Andre; Berberich, Anne; Heider, Sina; Müther, Michael; Bodensohn, Raphael; Behling, Felix
    Gender disparity regarding work-life balance satisfaction among German neuro-oncologists : A YoungNOA survey
    In: Neuro-Oncology, Jg. 24, 2022, Nr. 9, S. 1609 – 1611
    DOI (Open Access)
  • Lazaridis, Lazaros; Kebir, Sied; Glas, Martin
    Medikamentöse Therapie der häufigsten Hirnmetastasen
    In: Die Onkologie, Jg. 28, 2022, Nr. 5, S. 389 – 394
    DOI
  • Oster, Christoph; Kebir, Sied; Glas, Martin
    Meningeosis neoplastica : Epidemiologie, Diagnostik und Therapie
    In: Die Onkologie, Jg. 28, 2022, Nr. 7, S. 395 – 404
    DOI
  • Schmidt, Teresa; Kebir, Sied; Livingstone, Elisabeth; Junker, Andreas; Zülow, Stefan; Lazaridis, Lazaros; Oster, Christoph; Chorti, Eleftheria; Pierscianek, Daniela; Pul, Refik; Keyvani, Kathy; Sure, Ulrich; Stuschke, Martin; Kleinschnitz, Christoph; Scheffler, Björn; Zimmer, Lisa; Glas, Martin
    Case Report : Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma
    In: Frontiers in Oncology, Jg. 11, 2021, S. 637185
    DOI, Online Volltext (Open Access)
  • Shi, Wenyin; Blumenthal, Deborah T.; Bush, Nancy Ann Oberheim; Kebir, Sied; Lukas, Rimas V.; Muragaki, Yoshihiro; Zhu, Jay‑Jiguang; Glas, Martin
    Correction to : Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice (Journal of Neuro-Oncology, (2020), 148, 3, (489-500), 10.1007/s11060-020-03540-6)
    In: Journal of Neuro-Oncology, Jg. 151, 2021, Nr. 2, S. 339
    DOI (Open Access)
  • Pierscianek, Daniela; Ahmadipour, Yahya; Michel, Anna; Rauschenbach, Laurèl; Darkwah Oppong, Marvin; Deuschl, Cornelius; Kebir, Sied; Wrede, Karsten; Glas, Martin; Stuschke, Martin; Sure, Ulrich; Jabbarli, Ramazan
    Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma
    In: Clinical Neurology and Neurosurgery, Jg. 200, 2021, 106348
    DOI
  • Jabbarli, Ramazan; Ahmadipour, Yahya; Rauschenbach, Laurèl; Santos, Alejandro N.; Darkwah Oppong, Marvin; Pierscianek, Daniela; Quesada, Carlos M.; Kebir, Sied; Dammann, Philipp; Guberina, Nika; Scheffler, Björn; Kaier, Klaus; Stuschke, Martin; Sure, Ulrich; Wrede, Karsten
    How about levetiracetam in glioblastoma? An institutional experience and meta‐analysis
    In: Cancers, Jg. 13, 2021, Nr. 15, 3770
    DOI, Online Volltext (Open Access)
  • Tzaridis, Theophilos; Schäfer, Niklas; Weller, Johannes; Steinbach, Joachim-Peter; Schlegel, Uwe; Seidel, Sabine; Sabel, Michael; Hau, Peter; Seidel, Clemens; Krex, Dietmar; Goldbrunner, Roland; Tonn, Jörg-Christian; Grauer, Oliver; Kebir, Sied; Schneider, Matthias; Schaub, Christina; Vatter, Hartmut; Coch, Christoph; Glas, Martin; Fimmers, Rolf; Pietsch, Torsten; Reifenberger, Guido; Herrlinger, Ulrich; Felsberg, Jörg
    MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy : Lessons learned from the CeTeG/NOA-09 trial
    In: International Journal of Cancer, Jg. 148, 2021, Nr. 7, S. 1695 – 1707
    DOI (Open Access)
  • Shi, Wenyin; Blumenthal, Deborah T.; Oberheim Bush, Nancy Ann; Kebir, Sied; Lukas, Rimas V.; Muragaki, Yoshihiro; Zhu, Jay-Jiguang; Glas, Martin
    Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
    In: Journal of Neuro-Oncology, Jg. 148, 2020, Nr. 3, S. 489 – 500
    DOI (Open Access)
  • Stoppek, Ann-Kathrin; Kebir, Sied; Junker, Andreas; Keyvani, Kathy; Zülow, Stefan; Lazaridis, Lazaros; Schmidt, Teresa; Pierscianek, Daniela; Stuschke, Martin; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Zimmer, Lisa; Glas, Martin
    Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report
    In: BMC Cancer, Jg. 19, 2019, Nr. 1, 995
    DOI, Online Volltext (Open Access)
  • Müller, Andreas; Jurcoane, Alina; Kebir, Sied; Ditter, Philip; Schrader, Felix; Herrlinger, Ulrich; Tzaridis, Theophilos; Mädler, Burkhard; Schild, Hans H.; Glas, Martin; Hattingen, Elke
    Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma
    In: Cancer Medicine, Jg. 6, 2017, Nr. 1, S. 89 – 99
    DOI (Open Access)
  • Herrlinger, Ulrich; Schäfer, Niklas; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Friedrich, Franziska; Rohde, Veit; Ringel, Florian; Schlegel, Uwe; Sabel, Michael; Ronellenfitsch, Michael W.; Uhl, Martin; Maciaczyk, Jaroslaw; Grau, Stefan; Schnell, Oliver; Hänel, Mathias; Krex, Dietmar; Vajkoczy, Peter; Gerlach, Rudiger; Kortmann, Rolf-Dieter; Mehdorn, Maximilian; Tuttenberg, Jochen; Mayer-Steinacker, Regine; Fietkau, Rainer; Brehmer, Stefanie; Mack, Frederic; Stuplich, Moritz; Kebir, Sied; Kohnen, Ralf; Dunkl, Elmar; Leutgeb, Barbara; Proescholdt, Martin; Pietsch, Torsten; Urbach, Horst; Belka, Claus; Stummer, Walter; Glas, Martin
    Bevacizumab Plus irinotecan versus temozolomide in newly diagnosed O⁶-methylguanine-DNA methyltransferase nonmethylated glioblastoma : The randomized GLARIUS trial
    In: Journal of Clinical Oncology (JCO), Jg. 34, 2016, Nr. 14, S. 1611 – 1619
    DOI
  • Kebir, Sied; Fimmers, Rolf; Galldiks, Norbert; Schafer, Niklas; Mack, Frederic; Schaub, Christina; Stuplich, Moritz; Niessen, Michael; Tzaridis, Theophilos; Simon, Matthias; Stoffels, Gabriele; Langen, Karl-Josef; Scheffler, Bjorn; Glas, Martin; Herrlinger, Ulrich
    Late Pseudoprogression in Glioblastoma : Diagnostic Value of Dynamic O-(2-[¹⁸ F]fluoroethyl)-L-Tyrosine PET
    In: Clinical Cancer Research, Jg. 22, 2016, Nr. 9, S. 2190 – 2196
    DOI
  • Korfel, Agnieszka; Schlegel, Uwe; Herrlinger, Ulrich; Dreyling, Martin; Schmidt, Christian; Von Baumgarten, Luisa; Pezzutto, Antonio; Grobosch, Thomas; Kebir, Sied; Thiel, Eckhard; Martus, Peter; Kiewe, Philipp
    Phase II trial of temsirolimus for relapsed/refractory primary CNS lymphoma
    In: Journal of Clinical Oncology (JCO), Jg. 34, 2016, Nr. 15, S. 1757 – 1763
    DOI, Online Volltext (Open Access)
  • Schaub, Christina; Tichy, Julia; Schäfer, Niklas; Franz, Kea; Mack, Frederic; Mittelbronn, Michel; Kebir, Sied; Thiepold, Anna-Luisa; Waha, Andreas; Filmann, Natalie; Banat, Mohammed; Fimmers, Rolf; Steinbach, Joachim P.; Herrlinger, Ulrich; Rieger, Johannes; Glas, Martin; Bähr, Oliver
    Prognostic factors in recurrent glioblastoma patients treated with bevacizumab
    In: Journal of Neuro-Oncology, Jg. 129, 2016, Nr. 1, S. 93 – 100
    DOI
  • Kebir, Sied; Orfanos, Zacharias; Schuld, Julia; Linhart, Markus; Lamberz, Christian; van der Ven, Peter F.M.; Schrickel, Jan; Kirfel, Gregor; Fürst, Dieter O.; Meyer, Rainer
    Sarcomeric lesions and remodeling proximal to intercalated disks in overload-induced cardiac hypertrophy
    In: Experimental Cell Research, Jg. 348, 2016, Nr. 1, S. 95 – 105
    DOI
  • Schaub, Christina; Schäfer, Niklas; Mack, Frederic; Stuplich, Moritz; Kebir, Sied; Niessen, Michael; Tzaridis, Theophilos; Banat, Mohammed; Vatter, Hartmut; Waha, Andreas; Herrlinger, Ulrich; Glas, Martin
    The earlier the better? : Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma
    In: Journal of Cancer Research and Clinical Oncology, Jg. 142, 2016, Nr. 8, S. 1825 – 1829
    DOI
  • Bualeong, Tippaporn; Kebir, Sied; Hof, Dorothea; Goelz, Lina; Graewe, Mathias; Ehrentraut, Stefan Felix; Knuefermann, Pascal; Baumgarten, Georg; Meyer, Rainer; Ehrentraut, Heidi
    Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overload
    In: Journal of Negative Results in BioMedicine, Jg. 15, 2016, Nr. 1, 9
    DOI (Open Access)
  • Kebir, Sied; Kimmich, Okka; Niehusmann, Pitt; Gaertner, Florian C.; Essler, Markus; Landsberg, Jennifer; Klockgether, Thomas; Simon, Matthias; Herrlinger, Ulrich; Glas, Martin
    ¹⁸F-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumor
    In: Oncology Letters, Jg. 12, 2016, Nr. 6, S. 4705 – 4707
    DOI (Open Access)
  • Kebir, Sied; Gaertner, Florian C.; Mueller, Marcus; Nelles, Michael; Simon, Matthias; Schäfer, Niklas; Stuplich, Moritz; Schaub, Christina; Niessen, Michael; Mack, Frederic; Bundschuh, Ralph; Greschus, Susanne; Essler, Markus; Glas, Martin; Herrlinger, Ulrich
    ¹⁸F–fluoroethyl–L–tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report
    In: Oncology Letters, Jg. 11, 2016, Nr. 3, S. 2195 – 2198
    DOI (Open Access)
  • Ehrentraut, Heidi; Ehrentraut, Stefan Felix; Boehm, Olaf; Aissati, Sakina El; Foltz, Fabian; Goelz, Lina; Goertz, David; Kebir, Sied; Weisheit, Christina; Wolf, Michael; Meyer, Rainer; Baumgarten, Georg; Felix Ehrentraut, Stefan; El Aissati, Sakina
    Tlr4 deficiency protects against cardiac pressure overload induced hyperinflammation
    In: PLoS ONE, Jg. 10, 2015, Nr. 11, e0142921
    DOI (Open Access)
  • Mack, Frederic; Schäfer, Niklas; Kebir, Sied; Stuplich, Moritz; Schaub, Christina; Niessen, Michael; Scheffler, Björn; Herrlinger, Ulrich; Glas, Martin
    Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma
    In: Oncology, Jg. 86, 2014, Nr. 5-6, S. 369 – 372
    DOI
  • Schaub, Christina; Greschus, Susanne; Seifert, Mirko; Waha, Andreas; Blasius, Elias; Rasch, Katja; Landwehr, Christiane; Mack, Frederic; Schäfer, Niklas; Stuplich, Moritz; Kebir, Sied; Vilz, Belinda; Scheffler, Björn; Boström, Jan; Simon, Matthias; Urbach, Horst; Glas, Martin; Herrlinger, Ulrich
    FLAIR-Only progression in bevacizumab-treated relapsing glioblastoma does not predict short survival
    In: Oncology, Jg. 85, 2013, Nr. 3, S. 191 – 195
    DOI
  • Wolf, M.; Lossdörfer, S.; Abuduwali, N.; Meyer, R.; Kebir, Sied; Götz, W.; Jäger, A.
    In vivo differentiation of human periodontal ligament cells leads to formation of dental hard tissue
    In: Journal of Orofacial Orthopedics, Jg. 74, 2013, Nr. 6, S. 494 – 505
    DOI
  • Boehm, Olaf; Knuefermann, Pascal; Plueck, Johannes; Schwederski, Markus; Ehrentraut, Heidi; Kebir, Sied; Lohner, Ralph; Velten, Markus; Morath, Siegfried; Koch, Alexander; Zacharowski, Kai; Grohé, Christian; Hoeft, Andreas; Baumgarten, Georg; Meyer, Rainer
    TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo
    In: Journal of Inflammation, Jg. 10, 2013, Nr. 1, 33
    DOI (Open Access)
  • Schäfer, Niklas; Scheffler, Björn; Stuplich, Moritz; Schaub, Christina; Kebir, Sied; Rehkam̈per, Claudia; Mack, Frederick; Niehusmann, Pitt; Simon, Matthias; Greschus, Susanne; Kuchelmeister, Klaus; Herrlinger, Ulrich; Glas, Martin
    Vemurafenib for leptomeningeal melanomatosis
    In: Journal of Clinical Oncology (JCO), Jg. 31, 2013, Nr. 11
    DOI
  • Wolf, Michael; Lossdörfer, Stefan; Abuduwali, Nuersailike; Meyer, Rainer; Kebir, Sied; Götz, Werner; Jäger, Andreas
    Effect of intermittent PTH(1-34) on human periodontal ligament cells transplanted into immunocompromised mice
    In: Tissue Engineering / Part A, Jg. 18, 2012, Nr. 17-18, S. 1849 – 1856
    DOI (Open Access)

    • Abstracts

  • Schmidt, T; Oezdemir, Z; Oster, C; Sure, Ulrich; Hermann, K; Stuschke, Martin; Deuschl, Cornelius; Kleinschnitz, Christoph; Müther, M; Glas, Martin; Kebir, Sied
    18-FET-PET Enhanced Diagnosis of Pseudoprogression in Glioblastome is an Independent Prognostic Fator for Overall Survival
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement_5, S. v49 – v50
    DOI
  • Kebir, Sied; Wilms, Sarah; Wenger, Katharina; Kessler, Almuth F; Pröscholdt, Martin; Harapan, Biyan N.; Quach, Stefanie; Hottinger, Andreas F.; Suchorska, Bogdana; Schmidt, Teresa; Oster, Christoph; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Glas, Martin
    AI Based Prediction of Clinical TTFields Response in Glioblastoma Patients (Retrospective Analysis)
    29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO): NOV 21-24, 2024; Houston, USA,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Suppl. 8: Abstracts from the 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, S. viii112 – viii112
    DOI
  • Oster, Christoph; Matyar, Aylin; Hummel, Thomas; Hattingen, Elke; Schmidt, Teresa; Jokisch, Martha; Jokisch, Daniel; Ahmadipour, Yahya; Sure, Ulrich; Stuschke, Martin; Tertel, Tobias; Giebel, Bernd; Kleinschnitz, Christoph; Scheffler, Björn; Deuschl, Cornelius; Kebir, Sied; Glas, Martin
    Decoding glioblastoma survival : Unraveling the prognostic potential of olfactory function in a prospective observational study
    29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO): NOV 21-24, 2024; Houston, USA,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Suppl. 8: Abstracts from the 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, S. viii95 – viii95
    DOI
  • Giordano, F.A.; Layer, J.P.; Friker, L.L.; Turiello, R.; Zeyen, T.; Pregler, B.; Mirallas, O.; Kebir, Sied; Renovanz, M.; Hambsch, P.; Pietsch, T.; Gkika, E.; Platten, M.; Schneider, M.; Grauer, O.; Tabatabai, G.; Glas, Martin; Seidel, C.; Herrlinger, U.; Hölzel, M.
    Dual inhibition of post-radiogenic angio-vasculogenesis in glioblastoma: Results of the phase I/II GLORIA trial
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S408
    DOI
  • Oster, Christoph; Kessler, Lukas; Blau, Tobias; Keyvani, Kathy; Pabst, Kim M; Fendler, Wolfgang P.; Fragoso Costa, Pedro; Lazaridis, Lazaros; Schmidt, Teresa; Feldheim, Jonas; Pierscianek, Daniela; Schildhaus, Hans-Ulrich; Sure, Ulrich; Ahmadipour, Yahya; Kleinschnitz, Christoph; Guberina, Nika; Stuschke, Martin; Deuschl, Cornelius; Scheffler, Björn; Herrmann, Ken; Kebir, Sied; Glas, Martin
    The Role Of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison Of Tissue, 68ga-Fapi-46 Positron Emission Tomography and Survival Data
    29th Annual Meeting and Education Day of the Society for Neuro-Oncology, November 21-24, 2024, Houston, TX, USA,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 8, S. viii196 – viii197
    DOI
  • Oster, C; Kessler, Lukas; Blau, T; Keyvani, Kathy; Pabst, K; Fendler, Wolfgang; Fragoso Costa, Pedro; Lazaridis, L; Schmidt, T; Feldheim, J; Pierscianek, D; Schildhaus, H; Sure, Ulrich; Ahmadipour, Y; Kleinschnitz, Christoph; Guberina, N; Stuschke, Martin; Deuschl, Cornelius; Scheffler, Björn; Herrmann, Ken; Kebir, Sied; Glas, Martin
    The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, 68GA-FAPI-46 Positron Emission Tomography and Survival Data
    19th Meeting of the European Association of Neuro-Oncology (EANO 2024), October 17-20, 2024, Glasgow, UK,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement 5, S. v25 – v25
    DOI
  • Kersting, David; Lazaridis, Lazaros; Barbato, Francesco; Kebir, Sied; Kümmel, Sherko; Welt, Anja; Umutlu, Lale; Milosevic, Aleksandar; Nader, Michael; Fragoso Costa, Pedro; Schmidt, T.; Oster, Christoph; Deuschl, Cornelius; Sure, Ulrich; Stuschke, Martin; Kleinschnitz, Christoph; Scheffler, Björn; Hautzel, Hubertus; Schuler, Martin; Glas, Martin; Fendler, Wolfgang; Herrmann, Ken
    68Ga-NeoB PET for Glioma and Breast Cancer : First Results from a Prospective Observational Trial
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S265
    DOI
  • Oster, Christoph; Hummel, Thomas; Hattingen, Elke; Schmidt, Teresa; Lazaridis, Lazaros; Jokisch, Daniel; Jokisch, Martha; Agkatsev, Sarina; Ahmadipour, Yahya; Sure, Ulrich; Stuschke, Martin; Kleinschnitz, Christoph; Scheffler, Björn; Deuschl, Cornelius; Kebir, Sied; Glas, Martin
    Decoding glioblastoma survival : unraveling the prognostic potential of olfactory function in a prospective observational study
    28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 5, S. v92 – v92
    DOI
  • Oster, Christoph; Blau, Tobias; Keyvani, Kathy; Schmidt, Teresa; Lazaridis, Lazaros; Agkatsev, Sarina; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Barbato, Francesco; Herrmann, Ken; Kebir, Sied; Glas, Martin
    Fet pet sensitivity in primary brain tumors according to cns who 2021 : value and pitfalls in presurgical implementation
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 5, S. v204 – v205
    DOI
  • Schmidt, Teresa; Rohn, Hana; Trilling, Mirko; Agkatsev, Sarina; Oster, Christoph; Kleinschnitz, Christoph; Sure, Ulrich; Stuschke, Martin; Scheffler, Björn; Kebir, Sied; Glas, Martin
    Immunogenicity of an additional dose of covid-19 vaccine in fully vaccinated patients with glioma to evaluate new national vaccination guidelines : a prospective cohort study
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 5, S. v63 – v64
    DOI
  • Giordano, Frank; Layer, Julian; Leonardelli, Sonia; Friker, Lea; Schaub, Christina; Zeyen, Thomas; Sperk, Elena; Hambsch, Peter; Oster, Christoph; Grau, Franziska; Paech, Daniel; Müller, Wolf; Pietsch, Torsten; Schmeel, L Christopher; Grauer, Oliver; Renovanz, Mirjam; Tabatabai, Ghazaleh; Kebir, Sied; Bisdas, Sotirios; Güresir, Erdem; Glas, Martin; Seidel, Clemens; Hölzel, Michael; Herrlinger, Ulrich
    Interim data on dual inhibition of post-radiogenic angio-vasculogenesis by olaptesed pegol (nox-a12) and bevacizumab in glioblastoma from the first expansion arm of the phase 1/2 gloria trial
    28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 5, S. v90 – v91
    DOI
  • Kebir, Sied; Lazaridis, Lazaros; Schmidt, Teresa; Oster, Christoph; Feldheim, Jonas; Pierscianek, Daniela; Proescholdt, Martin; Hau, Peter; Grosu, Anca-Ligia; Krex, Dietmar; Sure, Ulrich; Scheffler, Björn; Kleinschnitz, Christoph; Pöttgen, Christoph; Stuschke, Martin; Glas, Martin
    Investigating safety and efficacy of ttfields prior and concomitant to radiotherapy in newly diagnosed glioblastoma : First results of the pricottf phase I/II trial
    28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 5, S. v91 – v92
    DOI
  • Oster, C; Blau, T; Keyvani, Kathy; Schmidt, T; Lazaridis, L; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Herrmann, Ken; Barbato, F; Kebir, Sied; Glas, Martin
    P15.01.A FET PET Sensitivity in primary brain tumors according to CNS who 2021 : Value and pitfalls in presurgical implementation
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 2, S. ii109 – ii109
    DOI, Online Volltext (Open Access)
  • Ullrich, Vivien; Ertmer, Sarah; Berger, Pia; Langer, Sarah; Baginska, Anna; Gull, Hanah; Dorsch, Madeleine; Cima, Igor; Dobersalske, Celia; Kebir, Sied; Glas, Martin; Rauschenbach, Laurèl; Sure, Ulrich; Rösch, Alexander; Grüner, Barbara M.; Scheffler, Björn
    Predicting and targeting clonally expanding, tmz-resistant tumor cells in glioblastoma
    28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 5, S. v110 – v110
    DOI
  • Kebir, Sied; Lazaridis, Lazaros; Schmidt, Teresa; Oster, Christoph; Feldheim, Jonas; Proescholdt, Martin; Grosu, Anca Ligia; Krex, Dietmar; Pierscianek, Daniela; Sure, Ulrich; Scheffler, Björn; Kleinschnitz, Christoph; Stuschke, Martin; Glas, Martin
    Safety and efcacy of TTFields therapy prior and concomitant to radiotherapy in newly diagnosed glioblastoma : the PriCoTTF phase I/II trial
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S32
    DOI (Open Access)
  • Leonardelli, S.; Layer, J.P.; Friker, L.L.; Turiello, R.; van der Voort, G.; Corvino, D.; Schaub, C.; Müller, W.; Sperk, E.; Schmeel, L.C.; Sahm, K.; Kebir, Sied; Hambsch, P.; Pietsch, T.; Thurley, K.; Glas, M.; Seidel, C.; Herrlinger, U.; Giordano, F.A.; Hölzel, M.
    Spatial remodeling of the immune tumor microenvironment after radiotherapy and CXCL12 inhibition in glioblastoma in the phase I/II GLORIA trial
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S395
    DOI
  • Feldheim, J; Schmidt, T; Oster, Christoph; Feldheim, J; Sure, Ulrich; Kleinschnitz, Christoph; Lazaridis, Lazaros; Kebir, Sied; Glas, Martin
    Telemedicine in Neuro-Oncology : An Evaluation of Remote Consultations during the COVID-19 Pandemic
    18th Meeting of the European Association of Neuro-Oncology, September 21-24, 2023, Rotterdam, The Netherlands,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Supplement 2, S. ii16 – ii17
    DOI, Online Volltext (Open Access)
  • Lazaridis, Lazaros; Mönninghoff, Christoph; Bumes, Elisabeth; Spille, Dorothee Cäcilia; Müther, Michael; Schulz, Tim; Heider, Sina; Agkatsev, Sarina; Schmidt, Teresa; Blau, Tobias; Oster, Christoph; Stummer, Walter; Kessler, Almuth Friederike; Seidel, Clemens; Grauer, Oliver; Hau, Peter; Sure, Ulrich; Keyvani, Kathy; Herrlinger, Ulrich; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin
    Temporal muscle thickness as a prognostic marker in a real-life cohort of newly diagnosed MGMT promoter methylated glioblastoma patients : a multicentric imaging analysis
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 25, 2023, Nr. Suppl. 5, S. v192 – v193
    DOI
  • Kebir, Sied; Pierscianek, Daniela; Proescholdt, Martin; Hau, Peter; Grosu, Anca-Ligia; Krex, Dietmar; Sure, Ulrich; Scheffler, Björn; Stuschke, Martin; Glas, Martin
    PriCoTTF Trial : A Phase I//II Trial of TTFields Prior and Concomitant to Radiotherapy in newly diagnosed Glioblastoma
    2021 Society for Neuro-Oncology’s 26th Annual Scientific Meeting and Education Day,
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 23, 2021, Nr. Supplement_6, S. vi68 – vi68
    DOI (Open Access)

    • Poster / Posterbeiträge

  • Oster, C; Matyar, A; Hummel, T; Hattingen, E; Schmidt, T; Jokisch, Martha; Jokisch, D; Ahmadipour, Y; Sure, Ulrich; Stuschke, Martin; Tertel, T; Giebel, Bernd; Kleinschnitz, Christoph; Scheffler, Björn; Deuschl, Cornelius; Kebir, Sied; Glas, M
    Decoding Glioblastoma Survival : Unraveling the Prognostic Potential of Olfactory Function in a Prospective Observational Study
    In: Neuro-Oncology. Oxford: Oxford University Press, Jg. 26, 2024, Nr. Supplement_5, S. v137 – v137
    DOI